Kidney International Supplements最新文献

{"title":"International Society of Nephrology Global Kidney Health Atlas: structures, organization and services for the management of kidney failure in North and East Asia","authors":"Luxia Zhang ,&nbsp;Jinwei Wang ,&nbsp;Chih-Wei Yang ,&nbsp;Sydney Chi-wai Tang ,&nbsp;Naoki Kashihara ,&nbsp;Yong-soo Kim ,&nbsp;Ariunaa Togtokh ,&nbsp;Syed Saad ,&nbsp;Feng Ye ,&nbsp;Maryam Khan ,&nbsp;Deenaz Zaidi ,&nbsp;Mohamed A. Osman ,&nbsp;Meaghan Lunney ,&nbsp;Ikechi G. Okpechi ,&nbsp;Vivekanand Jha ,&nbsp;David C.H. Harris ,&nbsp;Adeera Levin ,&nbsp;Marcello Tonelli ,&nbsp;David W. Johnson ,&nbsp;Aminu K. Bello ,&nbsp;Ming-hui Zhao","doi":"10.1016/j.kisu.2021.01.011","DOIUrl":"10.1016/j.kisu.2021.01.011","url":null,"abstract":"<div><p>Kidney failure (KF) is a public health<span><span><span> problem in all regions of the world. We aim to provide comprehensive information regarding the disease burden of KF and capacity for providing optimal care in the International Society of </span>Nephrology<span> North and East Asia region based on data from the International Society of Nephrology Global Kidney Health Atlas project. Seven of eight jurisdictions participated, and wide variation was found in terms of KF burden and care capacity. Prevalence of long-term dialysis ranged from 88.4 per million population in mainland China to 3251 per million population in Taiwan. Hemodialysis was the predominant modality of dialysis in all jurisdictions, except for Hong Kong, where </span></span>peritoneal dialysis<span> (PD) was much more prevalent than hemodialysis. All jurisdictions provided public funding for kidney replacement therapy (dialysis and transplantation). Although the frequency and duration of hemodialysis followed a standard pattern in all investigated jurisdictions, the density of nephrologists and kidney replacement therapy centers varied according to income level. Conservative care, whether medically advised or chosen by patients, was available in most jurisdictions. All jurisdictions had official registries for KF and recognized KF as a health priority. These comprehensive data provide information about the burden of KF and capacity to provide optimal care in North and East Asia, which varied greatly across jurisdictions in the region.</span></span></p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"11 2","pages":"Pages e77-e85"},"PeriodicalIF":5.5,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2021.01.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38986995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Newly Independent States and Russia","authors":"Elena Zakharova ,&nbsp;Abduzhappar Gaipov ,&nbsp;Aminu K. Bello ,&nbsp;David W. Johnson ,&nbsp;Vivekanand Jha ,&nbsp;David C.H. Harris ,&nbsp;Adeera Levin ,&nbsp;Syed Saad ,&nbsp;Maryam Khan ,&nbsp;Deenaz Zaidi ,&nbsp;Mohamed A. Osman ,&nbsp;Feng Ye ,&nbsp;Meaghan Lunney ,&nbsp;Marcello Tonelli ,&nbsp;Ikechi G. Okpechi ,&nbsp;Alexander Zemchenkov ,&nbsp;Irma Tchokhonelidze ,&nbsp;ISN Newly Independent States and Russia Regional Board","doi":"10.1016/j.kisu.2021.01.003","DOIUrl":"10.1016/j.kisu.2021.01.003","url":null,"abstract":"<div><p><span><span>The International Society of Nephrology<span> Global Kidney Health Atlas analyzed the current state of kidney care in Newly Independent States and Russia. Our results demonstrated that the Newly Independent States and Russia region was not an exception and showed the same effect of chronic kidney disease on health and its outcomes, facing many difficulties and challenges in terms of improving kidney care across the countries. This work summarized and presented demographics, </span></span>health information systems<span><span>, statistics, and national health policy of the region, as well as characteristics of the burden of chronic kidney disease and kidney failure (KF) of participating countries. Besides significant economic advancement in the region, the collected data revealed existing shortage in KF care providers, essential medications, and health product access for KF care. Moreover, there was low reporting of kidney replacement therapy<span> (dialysis and kidney transplantation) quality indicators and low capacity for long-term hemodialysis, </span></span>peritoneal dialysis<span>, and kidney transplantation. The financial issues and funding structures for KF care across the region needs strategic support for fundamental changes and further advancement. This article emphasizes the urgent need for further effective regional and international collaborations and partnership for establishment of </span></span></span>universal health care systems for KF management.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"11 2","pages":"Pages e57-e65"},"PeriodicalIF":5.5,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2021.01.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38986993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Eastern and Central Europe","authors":"Alicja Dębska-Ślizień ,&nbsp;Aminu K. Bello ,&nbsp;David W. Johnson ,&nbsp;Vivekanand Jha ,&nbsp;David C.H. Harris ,&nbsp;Adeera Levin ,&nbsp;Marcello Tonelli ,&nbsp;Syed Saad ,&nbsp;Deenaz Zaidi ,&nbsp;Mohamed A. Osman ,&nbsp;Feng Ye ,&nbsp;Maryam Khan ,&nbsp;Meaghan Lunney ,&nbsp;Ikechi G. Okpechi ,&nbsp;Rumeyza Turan Kazancioglu ,&nbsp;ISN Eastern and Central Europe Regional Board","doi":"10.1016/j.kisu.2021.01.008","DOIUrl":"10.1016/j.kisu.2021.01.008","url":null,"abstract":"<div><p><span><span><span>Provision of adequate kidney care for patients with chronic kidney disease or kidney failure (KF) is costly and requires extensive resources. There is an inequality in the global distribution of wealth and resources needed to provide this care. In this second iteration of the International Society of </span>Nephrology<span> Global Kidney Health Atlas, we present data for countries in Eastern and Central Europe. In the region, the median prevalence of chronic kidney disease was 13.15% and treated KF was 764 per million population, respectively, slightly higher than the global median of 759 per million population. In most countries in the region, over 90% of dialysis patients were on hemodialysis and patients with a functioning graft represented less than one-third of total patients with treated KF. The median annual costs for maintenance hemodialysis were close to the global median, and public funding provided nearly universal coverage of the costs of </span></span>kidney replacement therapy. Nephrologists were primarily responsible for KF care. All countries had the capacity to provide long-term hemodialysis, and 95% had the capacity to provide </span>peritoneal dialysis<span><span>. Home hemodialysis was generally not available. </span>Kidney transplantation and conservative care were available across most of the region. Almost all countries had official dialysis and transplantation registries. Eastern and Central Europe is a region with a high burden of chronic kidney disease and variable capacity to deal with it. Insufficient funding and workforce shortages coupled with increasing comorbidities among aging patients and underutilization of cost-effective dialysis therapies such as peritoneal dialysis and kidney transplantation may compromise the quality of care for patients with KF. Some workforce shortages could be addressed by improving the organization of nephrological care in some countries of the region.</span></p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"11 2","pages":"Pages e24-e34"},"PeriodicalIF":5.5,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2021.01.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38986990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Africa","authors":"Fidelis Oguejiofor ,&nbsp;Daniel S. Kiggundu ,&nbsp;Aminu K. Bello ,&nbsp;Charles R. Swanepoel ,&nbsp;Gloria Ashuntantang ,&nbsp;Vivekanand Jha ,&nbsp;David C.H. Harris ,&nbsp;Adeera Levin ,&nbsp;Marcello Tonelli ,&nbsp;Abdou Niang ,&nbsp;Nicola Wearne ,&nbsp;Mothusi Walter Moloi ,&nbsp;Ifeoma Ulasi ,&nbsp;Fatiu A. Arogundade ,&nbsp;Syed Saad ,&nbsp;Deenaz Zaidi ,&nbsp;Mohamed A. Osman ,&nbsp;Feng Ye ,&nbsp;Meaghan Lunney ,&nbsp;Timothy O. Olanrewaju ,&nbsp;Ikechi G. Okpechi","doi":"10.1016/j.kisu.2021.01.009","DOIUrl":"10.1016/j.kisu.2021.01.009","url":null,"abstract":"<div><p><span><span>Despite positive economic forecasts, stable democracies, and reduced regional conflicts since the turn of the century, Africa continues to be afflicted by poverty, poor infrastructure, and a massive burden of communicable diseases such as HIV, malaria, tuberculosis, and diarrheal illnesses. With the rising prevalence of chronic kidney disease and kidney failure worldwide, these factors continue to hinder the ability to provide kidney care for millions of people on the continent. The International Society of </span>Nephrology<span> Global Kidney Health Atlas project was established to assess the global burden of kidney disease and measure global capacity for </span></span>kidney replacement therapy (dialysis and kidney transplantation). The aim of this second iteration of the International Society of Nephrology Global Kidney Health Atlas was to evaluate the availability, accessibility, affordability, and quality of kidney care worldwide. We identified several gaps regarding kidney care in Africa, chief of which are (i) severe workforce limitations, especially in terms of the number of nephrologists; (ii) low government funding for kidney care; (iii) limited availability, accessibility, reporting, and quality of provided kidney replacement therapy; and (iv) weak national strategies and advocacy for kidney disease. We also identified that within Africa, the availability and accessibility to kidney replacement therapy vary significantly, with North African countries faring far better than sub-Sahara African countries. The evidence suggests an urgent need to increase the workforce and government funding for kidney care, collect adequate information on the burden of kidney disease from African countries, and develop and implement strategies to enhance disease prevention and control across the continent.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"11 2","pages":"Pages e11-e23"},"PeriodicalIF":5.5,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2021.01.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38986989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Oceania and South East Asia","authors":"Isabelle Ethier ,&nbsp;David W. Johnson ,&nbsp;Aminu K. Bello ,&nbsp;Feng Ye ,&nbsp;Mohamed A. Osman ,&nbsp;Adeera Levin ,&nbsp;David C.H. Harris ,&nbsp;Peter Kerr ,&nbsp;Adrian Liew ,&nbsp;Muh Geot Wong ,&nbsp;Meaghan Lunney ,&nbsp;Syed Saad ,&nbsp;Deenaz Zaidi ,&nbsp;Maryam Khan ,&nbsp;Vivekanand Jha ,&nbsp;Marcello Tonelli ,&nbsp;Ikechi G. Okpechi ,&nbsp;Andrea K. Viecelli ,&nbsp;ISN Oceania and South East Asia Regional Board","doi":"10.1016/j.kisu.2021.01.004","DOIUrl":"10.1016/j.kisu.2021.01.004","url":null,"abstract":"<div><p><span><span>Oceania and South East Asia (OSEA) is a socioeconomically, culturally, and ethnically diverse region facing a rising epidemic of noncommunicable diseases<span>, including chronic kidney disease (CKD). The second iteration of the International Society of </span></span>Nephrology Global Kidney Health Atlas aimed to provide a comprehensive evaluation of kidney care in OSEA. Of the 30 countries/territories in OSEA, 15 participated in the survey, representing 98.5% of the region’s population. The median prevalence of treated kidney failure in OSEA was 1352 per million population (interquartile range, 966–1673 per million population), higher than the global median of 787 per million population. Although the general availability, access, and quality of </span>kidney replacement therapy<span> (i.e., dialysis and transplantation) was high in OSEA, inequalities in accessibility and affordability of kidney replacement therapy across the region resulted in variability between countries. According to the survey results, in a third of the participating countries (mostly lower-income countries), less than half the patients with kidney failure were able to access dialysis, whereas it was readily available to all with minimal out-of-pocket costs in high-income countries; similar variability in access to transplantation was also recorded. Limitations in workforce and resources vary across the region and were disproportionately worse in lower-income countries. There was little advocacy for kidney disease, moderate use of registries, restricted CKD detection programs, and limited availability of routine CKD testing in some high-risk groups across the region. International collaborations, as seen in OSEA, are important initiatives to help close the gaps in CKD care provision across the region and should continue receiving support from the global nephrology community.</span></p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"11 2","pages":"Pages e86-e96"},"PeriodicalIF":5.5,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2021.01.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38976566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe","authors":"Dearbhla M. Kelly ,&nbsp;Hans-Joachim Anders ,&nbsp;Aminu K. Bello ,&nbsp;Gabriel Choukroun ,&nbsp;Rosanna Coppo ,&nbsp;Gavin Dreyer ,&nbsp;Kai-Uwe Eckardt ,&nbsp;David W. Johnson ,&nbsp;Vivekanand Jha ,&nbsp;David C.H. Harris ,&nbsp;Adeera Levin ,&nbsp;Meaghan Lunney ,&nbsp;Valerie Luyckx ,&nbsp;Hans-Peter Marti ,&nbsp;Piergiorgio Messa ,&nbsp;Thomas F. Mueller ,&nbsp;Syed Saad ,&nbsp;Benedicte Stengel ,&nbsp;Raymond C. Vanholder ,&nbsp;Talia Weinstein ,&nbsp;Eric Rondeau","doi":"10.1016/j.kisu.2021.01.007","DOIUrl":"10.1016/j.kisu.2021.01.007","url":null,"abstract":"<div><p>Populations in the high-income countries of Western Europe are aging due to increased life expectancy. As the prevalence of diabetes and obesity has increased, so has the burden of kidney failure. To determine the global capacity for kidney replacement therapy<span><span> and conservative kidney management, the International Society of Nephrology<span> conducted multinational, cross-sectional surveys and published the findings in the International Society of Nephrology Global Kidney Health Atlas. In the second iteration of the International Society of Nephrology Global Kidney Health Atlas, we aimed to describe the availability, accessibility, quality, and affordability of kidney failure care in Western Europe. Among the 29 countries in Western Europe, 21 (72.4%) responded, representing 99% of the region’s population. The burden of kidney failure prevalence varied widely, ranging from 760 per million population (pmp) in Iceland to 1612 pmp in Portugal. Coverage of kidney replacement therapy from public funding was nearly universal, with the exceptions of Germany and Liechtenstein where part of the costs was covered by mandatory insurance. Fourteen (67%) of 21 countries charged no fees at the point of care delivery, but in 5 countries (24%), patients do pay some out-of-pocket costs. Long-term dialysis services (both hemodialysis and peritoneal dialysis) were available in all countries in the region, and </span></span>kidney transplantation<span> services were available in 19 (90%) countries. The incidence of kidney transplantation varied widely between countries from 12 pmp in Luxembourg to 70.45 pmp in Spain. Conservative kidney care was available in 18 (90%) of 21 countries. The median number of nephrologists was 22.9 pmp (range: 9.47–55.75 pmp). These data highlight the uniform capacity of Western Europe to provide kidney failure care, but also the scope for improvement in disease prevention and management, as exemplified by the variability in disease burden and transplantation rates.</span></span></p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"11 2","pages":"Pages e106-e118"},"PeriodicalIF":5.5,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2021.01.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38976569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Global variation in kidney care: national and regional differences in the care and management of patients with kidney failure","authors":"Aminu K. Bello ,&nbsp;Ikechi G. Okpechi ,&nbsp;Vivekanand Jha ,&nbsp;David C.H. Harris ,&nbsp;Adeera Levin ,&nbsp;David W. Johnson","doi":"10.1016/j.kisu.2020.11.003","DOIUrl":"10.1016/j.kisu.2020.11.003","url":null,"abstract":"","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"11 2","pages":"Pages e1-e3"},"PeriodicalIF":5.5,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2020.11.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38986988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Subscription Information","authors":"","doi":"10.1016/S2157-1716(21)00049-6","DOIUrl":"https://doi.org/10.1016/S2157-1716(21)00049-6","url":null,"abstract":"","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"11 2","pages":"Page A2"},"PeriodicalIF":5.5,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2157-1716(21)00049-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72066810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment of anemia in difficult-to-manage patients with chronic kidney disease","authors":"Ritesh Raichoudhury ,&nbsp;Bruce S. Spinowitz","doi":"10.1016/j.kisu.2020.12.006","DOIUrl":"10.1016/j.kisu.2020.12.006","url":null,"abstract":"<div><p>The management of anemia of chronic kidney disease (CKD) is often challenging. In particular, for patients with underlying inflammation, comorbid type 2 diabetes or cancer, those hospitalized, and recipients of a kidney transplant, the management of anemia may be suboptimal. Responsiveness to iron and/or erythropoiesis-stimulating agents, the mainstay of current therapy, may be reduced and the risk of adverse reactions to treatment is increased in these difficult-to-manage patients with anemia of CKD. This review discusses the unique patient and disease characteristics leading to complications and suboptimal treatment response. New treatment options in clinical development, such as hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitors, may be particularly useful for difficult-to-treat patients. In clinical studies, HIF-PH inhibitors provided increased hemoglobin levels and improved iron utilization in anemic patients with non–dialysis-dependent and dialysis-dependent CKD, and preliminary data suggest that HIF-PH inhibitors may be equally effective in patients with or without underlying inflammation. The availability of new treatment options, including HIF-PH inhibitors, may improve treatment outcomes in difficult-to-manage patients with anemia of CKD.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"11 1","pages":"Pages 26-34"},"PeriodicalIF":5.5,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2020.12.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25525348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anemia management: a historical perspective","authors":"Steven Fishbane","doi":"10.1016/j.kisu.2020.12.004","DOIUrl":"10.1016/j.kisu.2020.12.004","url":null,"abstract":"","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"11 1","pages":"Pages 3-7"},"PeriodicalIF":5.5,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2020.12.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47872975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}